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Abstract: Cancer remains a leading cause of death worldwide and traditional treatments such as
surgical resection, chemotherapy, and radiotherapy may have limited benefits depending on the
type of cancer and the stage at which it is diagnosed. Immunity is the state of protection against
foreign pathogens or substances (i.e., antigens). Recent research into novel approaches to
treatment has suggested that immunotherapy, which aims to optimize the body’s own natural
responses to combating disease through various mechanisms, may be a promising strategy that
can improve prognosis for certain cancer types that are refractory to other treatment options.
Quantitative models simulating the dynamics of tumor-immune system interaction, can
facilitate both basic and clinical research efforts aimed at better understanding the impact of
immunotherapy in the management of the disease. The presence of tumor cells stimulates the
response of the natural killer (NK) cells. To destroy cancer cells, the NK cells must have the
ability to bind to the cancerous cells through proteins. The binding process is successful only if
the surfaces of the two cells types have features which make them compatible. Thus, there exists
a time delay until immunotherapeutic effects are felt by the human body. Previous studies of
these dynamics have been described by various versions of predator-prey models. The goal of
this study is to expand on previous work by proposing an evolutionary revised predator-prey
mathematical model that employs discrete delays. The discrete delay is incorporated in a
logistic type rate-limiting recruitment term from the effector cell evolution equation. This model
suggests that tumor cells decline sharply according to the effects of these characteristic delays.
We analyze the system of differential equations using the steady state, stability techniques, and
critical values relevant to explaining the impact of therapy on tumor reduction. A comparison
between Michaelis-Menten and our modified logistic dynamics suggests that conclusions can be
drawn from the oscillatory behavior of the latter model. Through sensitivity analysis, we
determine that the most influential parameters that describe the model are the ones belonging to
the effector cells evolution equation. Thus, our analysis suggests that under certain conditions it
is possible not only to control tumor growth but also to reduce its size through the administration
of immunotherapy.
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